Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 7/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.32 |
| ▸ | YAP1 | P46937 | 1/20 | 0.32 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.32 |
| ▸ | TEAD2 | Q15562 | 1/20 | 0.32 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.31 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.31 |
| ▸ | IARS2 | Q9NSE4 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5028753 | 0.95 | LMNA (0.57) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL3718498 | 0.91 | LMNA (0.56) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL7995861 | 0.90 | LMNA (0.55) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL9009053 | 0.85 | LMNA (0.58) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL14958965 | 0.85 | LMNA (0.54) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL13041034 | 0.85 | LMNA (0.54) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL11292903 | 0.85 | LMNA (0.59) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL8905699 | 0.85 | LMNA (0.55) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL23188236 | 0.84 | LMNA (0.53) | LMNACYP2C19HIF1AEGFRSRC | |
| SCHEMBL5030922 | 0.84 | LMNA (0.60) | LMNACYP2C19HIF1AEGFRSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116421744-A | Absorbable medical hydrogel and preparation method thereof | 杭州融华再生医学科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| EP-0839056-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-09-13 | — | — | EP | claimed |
| EP-0886634-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-08-02 | — | — | EP | claimed |
| EP-0886634-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0839056-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-05-06 | — | — | EP | claimed |
| WO-1997027172-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1997-07-31 | — | — | WO | claimed |
| WO-1996040286-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| CN-116421744-B | Absorbable medical hydrogel and preparation method thereof | 杭州融华再生医学科技有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-116421744-A | Absorbable medical hydrogel and preparation method thereof | 杭州融华再生医学科技有限公司 | 2023-07-14 | — | — | CN | disclosed |
| US-6596904-B1 | Process for producing ioversol | MALLINC KRODT INC | 2003-07-22 | — | — | US | disclosed |
| EP-0839056-B1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT INC (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-0886634-B1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT INC (US) | 2002-04-24 | — | — | EP | disclosed |
| EP-0839056-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-0886634-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-0886634-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0839056-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997027172-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| US-5648536-A | Process for producing ioversol | LAFAYETTE PHARMACEUTICALS LLC | 1997-07-15 | — | — | US | disclosed |
| WO-1996040286-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1996-12-19 | — | — | WO | disclosed |